Study of Topical Calcitriol in Children With Psoriasis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00006275|
Recruitment Status : Completed
First Posted : September 12, 2000
Last Update Posted : June 24, 2005
I. Determine the therapeutic efficacy and safety of topical calcitriol in children with psoriasis.
|Condition or disease||Intervention/treatment||Phase|
|Psoriasis||Drug: calcitriol||Not Applicable|
PROTOCOL OUTLINE: Patients apply topical calcitriol in petrolatum on a psoriatic lesion daily. Patients also apply petrolatum without calcitriol to another psoriatic lesion daily.
Patients have both lesions photographed prior to therapy, monthly during therapy, and at the completion of therapy. Lesions are assessed weekly for 1 month and then every 2 weeks while on study. Blood samples are collected every 1 to 2 months and urine samples are collected every 2 weeks while on study.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||20 participants|
|Study Start Date :||July 2000|
|Study Completion Date :||July 2000|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00006275
|Study Chair:||Michael F. Holick||Boston University|